PROGNOSTIC FACTORS AND SURVIVAL IN MULTIPLE-MYELOMA - ANALYSIS OF 91 CASES TREATED BY MELPHALAN AND PREDNISONE

被引：0
|
作者：
GOBBI, M
CAVO, M
SAVELLI, G
BACCARANI, M
TURA, S
机构：
[1] UNIV BOLOGNA,CATTEDRA EMATOL,I-40126 BOLOGNA,ITALY
[2] UNIV TRIESTE,INSEGNAMENTO EMATOL,I-34127 TRIESTE,ITALY
来源：
HAEMATOLOGICA | 1980年 / 65卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 445
页数：9
相关论文
共 50 条
  • [1] DOSE INTENSITY ANALYSIS OF MELPHALAN AND PREDNISONE IN MULTIPLE-MYELOMA
    PALMER, M
    BELCH, A
    HANSON, J
    BROX, L
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (06): : 414 - 418
  • [2] NO CORRELATION BETWEEN RESPONSE AND SURVIVAL IN PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH VINCRISTINE, MELPHALAN, CYCLOPHOSPHAMIDE, AND PREDNISONE
    BALDINI, L
    RADAELLI, F
    CHIORBOLI, O
    FUMAGALLI, S
    CRO, L
    SEGALA, M
    CESANA, BM
    POLLI, EE
    MAIOLO, AT
    CANCER, 1991, 68 (01) : 62 - 67
  • [3] MELPHALAN AND PREDNISONE - EFFECTIVE COMBINATION FOR TREATMENT OF MULTIPLE-MYELOMA
    COSTA, G
    ENGLE, RL
    SCHILLING, A
    CARBONE, P
    KOCHWA, S
    NACHMAN, RL
    GLIDEWELL, O
    AMERICAN JOURNAL OF MEDICINE, 1973, 54 (05): : 589 - 599
  • [4] ANALYSIS OF PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA
    GASSMANN, W
    HAFERLACH, T
    SCHMITZ, N
    KAYSER, W
    EULER, HH
    DREWS, J
    LOFFLER, H
    KLINISCHE WOCHENSCHRIFT, 1984, 62 (19): : 896 - 905
  • [5] PROGNOSTIC FACTORS IN MULTIPLE-MYELOMA TREATED WITH PREDNISOLONE AND SEQUENTIAL MELPHALAN AND IFOSFAMIDE - MIP COMBINATION CHEMOTHERAPY
    ADACHI, T
    ASANO, K
    SEZAKI, T
    TAKAHASHI, I
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1982, 36 (01) : 39 - 47
  • [6] TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND PREDNISONE GIVEN IN INTERMITTENT COURSES - REPORT OF 22 CASES
    COLCOMBET, P
    JOLY, J
    LAURENT, J
    MEUNIER, P
    VIGNON, G
    LYON MEDICAL, 1977, 237 (03): : 193 - 198
  • [7] PROGNOSTIC FACTORS WITH HIGH-DOSE MELPHALAN FOR REFRACTORY MULTIPLE-MYELOMA
    BARLOGIE, B
    ALEXANIAN, R
    SMALLWOOD, L
    CHESON, B
    DIXON, D
    DICKE, K
    CABANILLAS, F
    BLOOD, 1988, 72 (06) : 2015 - 2019
  • [8] Prognostic factors in advanced multiple myeloma patients treated with the association of bortezomib, melphalan, prednisone and thalidomide (VMPT)
    Palumbo, A.
    Gay, F.
    Ambrosini, M. T.
    Benevolo, G.
    Pregno, F.
    Pescosta, N.
    Callea, V
    Cangialosi, C.
    Caravita, T.
    Morabito, F.
    Musto, P.
    Larocca, A.
    Caltagirone, S.
    Avonto, I
    Cavallo, F.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 140 - 140
  • [9] PEPTICHEMIO, VINCRISTINE AND PREDNISONE VERSUS MELPHALAN AND PREDNISONE AS INDUCTION THERAPY IN MULTIPLE-MYELOMA
    RICCARDI, A
    MERLINI, G
    MONTECUCCO, C
    DANOVA, M
    UCCI, G
    CASSANO, E
    ASCARI, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 787 - 791
  • [10] IMPROVED SURVIVAL TIMES IN MULTIPLE-MYELOMA TREATED WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE AND BCNU - M-2 PROTOCOL
    CASE, DC
    LEE, BJ
    CLARKSON, BD
    AMERICAN JOURNAL OF MEDICINE, 1977, 63 (06): : 897 - 903
12345